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coupled receptors, including P2X7R,
activating the extracellular signal-
regulated kinase 1/2 signaling pathway,
and ﬁnally inducing Sema3A expres-
sion in human epidermal keratinocytes
(Figure 2d).
Although 70–90% of patients with
psoriasis also have pruritus, they are
rarely accompanied by intense itch as
in AD (Yosipovitch et al., 2000; Reich
and Szepietowski, 2007). We
previously showed that Sema3A
production was not reduced in the
epidermis of psoriatic patients with or
without itch (Taneda et al., 2011). In
contrast to AD, high levels of expression
of several antimicrobial peptides
including LL-37 were observed in psor-
iatic lesions (Ong et al., 2002; Nomura
et al., 2003), suggesting that epidermal
Sema3A expression is not reduced in
these patients. These ﬁndings suggest
that LL-37 may restore Sema3A produc-
tion in keratinocytes of certain patholo-
gical conditions such as psoriasis and
that the decreased epidermal Sema3A
production in AD lesional skin may be
partly caused by a breakdown in this
recovery system. Thus, the topical
application of LL-37, which not only
has antimicrobial activity but also
enhances Sema3A production, might
be a useful therapeutic strategy for AD.
CONFLICT OF INTEREST
The authors state no conﬂict of interest.
ACKNOWLEDGMENTS
This work was partly supported by KAKENHI
(Grant number 26860898) and by a grant of
Strategic Research Foundation Grant-aided Project
for Private Universities from MEXT (Grant number
S1311011).
Yoshie Umehara1, Yayoi Kamata1,
Mitsutoshi Tominaga1,
François Niyonsaba2,3,
Hideoki Ogawa1,2 and
Kenji Takamori1,4
1Institute for Environmental and Gender
Speciﬁc Medicine, Juntendo University
Graduate School of Medicine, Chiba,
Japan; 2Atopy (Allergy) Research Center,
Juntendo University Graduate School of
Medicine, Tokyo, Japan; 3Faculty of
International Liberal Arts, Juntendo
University, Tokyo, Japan and 4Department of
Dermatology, Juntendo University Urayasu
Hospital, Urayasu, Chiba, Japan
E-mail: ktakamor@juntendo.ac.jp
REFERENCES
Barlow PG, Findlay EG, Currie SM et al. (2014)
Antiviral potential of cathelicidins. Future
Microbiol 9:55–73
de Jongh GJ, Zeeuwen PL, Kucharekova M et al.
(2005) High expression levels of keratinocyte
antimicrobial proteins in psoriasis compared with
atopic dermatitis. J Invest Dermatol 125:1163–73
Negi O, Tominaga M, Tengara S et al. (2012)
Topically applied semaphorin 3A ointment
inhibits scratching behavior and improves skin
inﬂammation in NC/Nga mice with atopic
dermatitis. J Dermatol Sci 66:37–43
Niyonsaba F, Someya A, Hirata M et al. (2001)
Evaluation of the effects of peptide antibiotics
human β-defensins-1/-2 and LL-37 on hista-
mine release and prostaglandin D2 production
from mast cells. Eur J Immunol 31:1066–75
Niyonsaba F, Nagaoka I, Ogawa H et al. (2009)
Multifunctional antimicrobial proteins and
peptides: natural activators of immune sys-
tems. Curr Pharm Des 15:2393–413
Niyonsaba F, Ushio H, Hara M et al. (2010)
Antimicrobial peptides human β-defensins
and cathelicidin LL-37 induce the secretion
of a pruritogenic cytokine IL-31 by human
mast cells. J Immunol 184:3526–34
Nomura I, Goleva E, Howell MD et al. (2003)
Cytokine milieu of atopic dermatitis, as
compared to psoriasis, skin prevents induction
of innate immune response genes. J Immunol
171:3262–9
Ong PY, Ohtake T, Btandt C et al. (2002) Endogenous
antimicrobial peptides and skin infections in
atopic dermatitis. N Engl J Med 347:1151–60
Reich A, Szepietowski JC (2007) Mediators of
pruritus in psoriasis. Mediators Inﬂamm 2007:
64727
Schauber J, Gallo RL (2008) Antimicrobial peptides
and the skin immune defense system. J Allergy
Clin Immunol 122:261–6
Taneda K, Tominaga M, Negi O et al. (2011)
Evaluation of epidermal nerve density and
opioid receptor levels in psoriatic itch. Br J
Dermatol 165:277–84
Tominaga M, Ogawa H, Takamori K (2008)
Decreased production of semaphorin 3A in
the lesional skin of atopic dermatitis. Br J
Dermatol 158:842–4
Tominaga M, Takamori K (2014) Itch and nerve
ﬁbers with special reference to atopic dermatitis:
therapeutic implications. J Dermatol 41:205–12
Yamaguchi J, Nakamura F, Aihara M et al. (2008)
Semaphorin3A alleviates skin lesions
and scratching behavior in NC/Nga mice, an
atopic dermatitis model. J Invest Dermatol
128:2842–9
Yosipovitch G, Goon A, Wee J et al. (2000)
The prevalence and clinical characteristics
of pruritus among patients with extensive
psoriasis. Br J Dermatol 143:969–73
IL-10 Signaling in Dendritic Cells Attenuates
Anti-Leishmania major Immunity without Affecting
Protective Memory Responses
Journal of Investigative Dermatology (2015) 135, 2890–2894; doi:10.1038/jid.2015.236; published online 16 July 2015
TO THE EDITOR
Leishmania major (L. major) parasites
cause skin lesions and are transmitted
by sand ﬂies infecting millions of people
each year. Upon infection, the parasites
(promastigotes) are phagocytosed by
macrophages where they transform
into amastigotes and replicate. The
amastigotes are eventually released
and taken up by dendritic cells (DCs),
which activate naive T cells in skin-
draining lymph nodes (sdLNs). In L.
major–infected humans and mice on a
resistant background, DCs induce an
IFNγ-driven T-helper (Th) type-1/T cyto-
toxic (Tc) 1 response that stimulatesAccepted article preview online 22 June 2015; published online 16 July 2015
Abbreviations: DC, dendritic cell; IFN, interferon; IL, interleukin; L. major, Leishmania major; sdLN, skin-
draining lymph node; Th, T helper; Treg, regulatory T cell
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macrophages to secrete nitric oxide for
efﬁcient parasite killing (Sacks and
Noben-Trauth, 2002). Although the
cutaneous lesions ultimately heal, low
numbers of viable parasites persist at the
site of the lesion. On one hand, these
are required to maintain T-cell memory,
which confers immunity upon
reinfection (Belkaid et al., 2001). On
the other hand, the residual parasites
form a reservoir that can cause severe
disease upon reactivation.
The regulatory cytokine IL-10 acts on
many leukocytes including DCs (Moore
et al., 2001). IL-10 signaling is critical
during L. major infection and for
parasite persistence. IL-10-deﬁcient
(IL-10− /−) mice produce increased
amounts of IFNγ during the acute phase
of infection and completely clear the
parasites, resulting in sterile cure. As
this leads to a loss of T-cell memory,
IL-10− /− mice are susceptible to and
develop larger lesions than wild-type
mice upon reinfection. Moreover,
anti-IL-10 receptor antibody treatment
of healed animals facilitates the
clearance of L. major, demonstrating
the requirement of IL-10 in parasite
maintenance (Belkaid et al., 2001). In
line, transgenic BALB/c×C57BL/6 F1
mice constitutively expressing IL-10 in
MHC class II+ cells harbor higher
numbers of parasites, resulting in larger
lesions, and they fail to control the
infection despite a normal Th1 response
(Groux et al., 1999). Surprisingly,
transgenic C57BL/6 mice expressing
IL-10 under the control of the IL-2
promoter primarily in activated T cells
retain their resistance to L. major infec-
tion (Hagenbaugh et al., 1997).
DCs have the unique capacity to
balance skin immunity and tolerance
(Kautz-Neu et al., 2010) and are targets
of IL-10 both in vitro and in the skin
(Girard-Madoux et al., 2012). Moreover,
we recently discovered that Langerhans
cells, the unique DC population residing
in the epidermis, are negative regulators
of the anti-Leishmania response, which is
in part mediated by IL-10 (Kautz-Neu
et al., 2011). To what extent IL-10
control of DCs contributes to the pheno-
type of IL-10− /− animals and shapes
the anti-Leishmania immune response
remains elusive.
To this aim, we analyzed mice with a
DC-speciﬁc deletion of the IL-10 recep-
tor α (DC-IL10R− /−) (Girard-Madoux
et al., 2012). Animals were inoculated
with a physiologic dose of ~ 1,000
parasites per ear and DC-IL10R− /−
developed similar skin lesions as com-
pared with nontransgenic (non-TG)
controls (Figure 1a, left panel). The
number and frequency of skin-
inﬁltrating inﬂammatory cells, as deter-
mined by ﬂow cytometry, was compar-
able to non-TG mice in week 6 of
infection (data not shown) (Woelbing
et al., 2006). Notably, despite com-
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Figure 1. Enhanced clearance of L. major without loss of memory response in DC-IL10R− /− mice. Animals on a resistant C57BL/6 background were inoculated
intradermally with a low dose of infectious-stage L. major clone VI (MHOM/IL/80/Friedlin) promastigotes (103 per ear). (a) Left panel: lesion volumes were
measured weekly (longitudinally in one and the same mouse during the entire 16-week observation period) in three dimensions and are reported as ellipsoids
((a/2×b/2× c/2)× 4/3π). Mean± SEM of three combined experiments with n⩾ 5 mice per group and time point is shown. Right panel: 6 months after the primary
infection, mice were challenged with 103 infectious-stage L. major promastigotes per ear. ↓=Time point of reinfection (week 22). Mean± SEM of three combined
experiments with n⩾7 mice per group and time point is depicted. (b) Ear and spleen parasite numbers were determined at 6 weeks post infection using limiting
dilution assays. (c) In weeks 16 and 22, numbers of parasites in ear lesions were quantiﬁed using limiting dilution assays. In b and c, mean parasite loads are
shown as horizontal bars, and individual parasite counts/ear are shown as squares (n⩾ 9 mice per group). *Po0.05 comparing non-TG and DC-IL10R− /− groups
using Mann–Whitney test.
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parable lesion size at 6 weeks, the
number of parasites was signiﬁcantly
lower in the ears and spleen of DC-
IL10R− /− (Figure 1b), similar to what is
observed in IL-10− /− mice (Belkaid
et al., 2001). To further analyze the
antigen-speciﬁc T-cell response at
6 weeks, lesion-draining submandibular
LN cells were restimulated in vitro with
soluble L. major antigen (Figure 2a).
While Th1/Tc1-derived IFNγ was mod-
erately increased in the cultures of DC-
IL10R− /− as compared with non-TG
mice, Th2-associated IL-4 was signiﬁ-
cantly reduced. The overall IFNγ/IL-4
ratio from three independent
experiments was 4.6-fold higher in
DC-IL10R− /− cultures. Levels of Th2-
derived IL-5 and IL-13 were unaltered
(Figure 2a). To date, the role of IL-17A
for disease outcome in C57BL/6 mice is
not clear. In our low-dose infection
model, IL-17A was elevated in DC-
IL10R− /− mice (Figure 2a) without
leading to enhanced lesion develop-
ment and neutrophil recruitment
(Supplementary Figure S1a online).
Finally, the frequency of Foxp3+CD4+
regulatory T cells (Tregs) was compar-
able in transgenic and non-TG mice
(Supplementary Figure S1b online).
Moreover, despite comparable para-
site internalization by DCs in vitro, we
detected signiﬁcantly more IL-12p40,
IL-6, and TNFα in restimulated sdLN
cells of DC-IL10R− /− animals, whereas
IL-10 and IL-23 levels were comparable
to non-TG mice (Figure 2a and 2b,).
Although IL-6 and TNFα can be
derived from both activated DCs
and T cells (Sacks and Noben-Trauth,
2002; Girard-Madoux et al., 2012), in
particular, IL-12 is primarily secreted by
infected DCs and promotes the protec-
tive Th1 response (Mattner et al., 1997;
von Stebut et al., 1998). However, the
elevated presence of proinﬂammatory
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Figure 2. Enhanced Th1/Tc1 response in DC-IL10R− /− animals. Animals on a resistant C57BL/6 background were inoculated intradermally with a low dose of
infectious-stage L. major promastigotes (103 per ear). (a and b) In week 6, lesion-draining submandibular LN cells were restimulated with soluble Leishmania
antigen for 48 hours. Cytokine production was measured in the culture supernatants by Cytometric Bead Array according to the manufacturer’s instructions
(BD, Heidelberg, Germany). Mean± SEM of three individually analyzed mice per group is presented. One representative out of n⩾3 independent experiments
is depicted. *Po0.05 and **Po0.01 comparing non-TG and DC-IL10R− /− using Student’s t-test. (c) In week 16 (after complete healing) and week 22 (before
reinfection), antigen-speciﬁc cytokine release by LN cells from infected mice was determined by ELISA after restimulation with soluble Leishmania antigen (SLA).
Mean± SEM of n⩾9 individually analyzed mice per group is presented.
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IL-6 and TNFα (and maybe IL-17A)
in situ may prevent attenuated lesion
development despite the occurrence of
fewer parasites in the ears (Figure 1a
and b).
Our data indicate that augmented
production of IL-12, in combination
with elevated IL-6 and TNFα, induces
a shift in the Th1/Th2 balance, resulting
in more efﬁcient parasite killing. Hence,
IL-10 control of DCs is crucial to
regulate their cytokine production and
thereby the magnitude of the Th1/Tc1
response during leishmaniasis. At the
peak of the anti-Leishmania response,
IL-10 is abundantly produced at the site
of infection by innate immune cells
and CD4+ T cells, both of which could
contribute to govern DCs (Kamanaka
et al., 2006; Anderson et al., 2007).
Previously, we observed that IL-10
control of DCs is essential to govern
T-cell reactivation in the skin
rather than T-cell priming in sdLN
during contact hypersensitivity (Girard-
Madoux et al., 2012). The present data
suggest that IL-10 control of DCs may
also be crucial during L. major infection.
Notably, in DC-IL10R− /− mice, cells
other than DCs, in particular T cells, can
still be controlled by IL-10, which,
however, is not sufﬁcient to contain
the anti-Leishmania effector T-cell
response (Clausen and Girard-Madoux,
2013).
After healing of L. major infections,
Treg-derived IL-10 is crucial for the
maintenance of small numbers of resi-
dual parasites, which confer immunity
against reinfection, but can be detri-
mental to the host upon inappropriate
reactivation. In particular, DCs were
strongly suggested as targets of IL-10
during this latent phase (Belkaid et al.,
2001; Belkaid et al., 2002). We
therefore investigated L. major reinfec-
tion in healed DC-IL10R− /− mice. Six
months after the ﬁrst infection, mice
were inoculated with ~ 1,000 parasites
per ear. The resulting lesions were
similar in DC-IL10R− /− and non-TG
animals (Figure 1a, right panel), suggest-
ing that the antigen-speciﬁc memory
response remained intact in DC-
IL10R− /−, which was further corrobo-
rated by a similar DTH reaction to SLA
in vivo (Supplementary Figure S2
online). In addition, the restimulatory
capacity of non-TG and IL-10R− /− bone
marrow–derived DCs to induce IFNγ
production and proliferation of
in vivo primed T cells was similar
(Supplementary Figure S3 online). Thus,
the enhanced proinﬂammatory cytokine
secretion by IL-10R-deﬁcient DCs dur-
ing the initial infection is not sufﬁcient
to mount a Th1/Tc1 response capable of
total parasite clearance. In line, parasite
burden in the ears and spleens of both
the groups in week 16 after healing
of the primary infection and in week
22 (before reinfection) were similar
(Figure 1c). In addition, the cytokine
responses during steady state (after
healing and before reinfection) were
also comparable (Figure 2c). Thus, in
contrast to IL10− /− mice, there is no
sterile cure when IL-10 signaling is
ablated exclusively in DCs.
In conclusion, IL-10 control of DCs is
crucial to limit the magnitude of the
antigen-speciﬁc Th1/Tc1 response dur-
ing the acute phase of infection, similar
to what is observed in IL-10− /− mice
(Belkaid et al., 2001). On the other hand,
IL-10 signaling in DCs is dispensable
during the latent phase of infection,
when Treg-derived IL-10 is sufﬁcient to
promote residual parasite survival and
thereby retain T-cell memory, indepen-
dent of modulating DC function.
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Dact1 Regulates the Ability of 3T3-J2 Cells to Support
Proliferation of Human Epidermal Keratinocytes
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TO THE EDITOR
Efﬁcient expansion of tissue-speciﬁc
stem cells and progenitor cells is critical
for therapeutic strategies in regenerative
medicine. The cell line of 3T3-J2 cells
has been used clinically for expansion
of human primary epidermal keratino-
cytes (HPEKs; Green, 2008). Although
3T3-J2 cells were originally derived
from mouse embryonic ﬁbroblasts
(MEFs), they are vastly superior in their
ability to support long-term keratinocyte
proliferation (Supplementary Figure S1
online). Determining the mechanistic
basis for this effect may identify the
strategies to improve the efﬁcacy of
therapeutic expansion of epidermal
keratinocytes.
As Wnt/β-catenin signaling stimulates
keratinocyte proliferation (Lim et al.,
2013), we ﬁrst asked whether increased
Wnt expression by 3T3-J2 cells could
contribute to long-term keratinocyte
proliferation. However, gene expression
analysis showed that 3T3-J2 cells and
MEFs express Wnt ligands at similar
levels (data not shown), suggesting that
enhanced Wnt production by 3T3-J2
cells is unlikely to account for their
superior ability to support keratinocyte
proliferation. Unexpectedly, despite
similar levels of Wnt receptors and
inhibitors (data not shown), expression
of Axin2, a well-characterized Wnt/β-
catenin target, was signiﬁcantly lower in
3T3-J2 cells than in MEFs (Figure 1a),
suggesting that Wnt/β-catenin signaling
is reduced in 3T3-J2 cells. In support,
we found that 3T3-J2 cells expressed
a signiﬁcantly higher level of the
Wnt/β-catenin antagonist Dact1 (dapper
antagonist of b-catenin 1) (Cheyette
et al., 2002) than did MEFs (Figure 1b).
As Dact1 can inﬂuence both Wnt-
dependent and Wnt-independent signal-
ing (Kivimäe et al., 2011), we next set
out to determine whether Dact1 expres-
sion inﬂuenced the ability of 3T3-J2 cells
to support keratinocyte proliferation.
Notably, we found that silencing of
Dact1 in 3T3-J2 cells reduced keratino-
cyte proliferation with a corresponding
reduction in epidermal clone size in
clonogenic culture (Barrandon and
Green, 1987; Figure 1c–g and
Supplementary Figure S2a–c online).
As enforced Wnt/β-catenin signaling in
3T3-J2 cells by ectopically expressed
Wnt/β-catenin ligands had similar
effects on keratinocyte proliferation
(Supplementary Figure S3 online), these
results indicate that Dact1 has a critical
role in the ability of 3T3-J2 cells to
support keratinocyte proliferation,
potentially by attenuating Wnt/β-cate-
nin signaling in 3T3-J2 cells.
Although less proliferative, epidermal
clones in Dact1-silenced 3T3-J2 cell
culture expressed p63, a transcription
factor that is essential for the prolifera-
tive potential of epidermal stem cells
(Senoo et al., 2007), at a similar level as
those in control culture (Figure 1h).
Further, p63 phosphorylation, an
early epidermal differentiation marker
(Suzuki and Senoo, 2012), and expres-
sion of involucrin, a marker of terminal
differentiation (Banks-Schlegel and
Green, 1981), were similar in both
cultures (Figure 1i–k). Moreover, kerati-
nocytes from both cultures showed
similar clonogenic potential in subse-
quent passages (Figure 1l and Supple-
mentary Figure S2d online). These
results indicate that the loss of Dact1
in 3T3-J2 cells reduces proliferation of
keratinocytes without promoting their
differentiation.
As transforming growth factor-β
(Tgf-β) also inhibits proliferation of
keratinocytes without inﬂuencing their
differentiation (Shipley et al., 1986), we
next determined whether the Dact1-
dependent regulation of keratinocyte
proliferation by 3T3-J2 cells involved
Tgf-β. As HPEKs express Wnt/β-catenin
ligands (Lim et al., 2013), we ﬁrst asked
whether Dact1 silencing inﬂuenced
Tgf-β expression in response to
exogenous Wnt stimulation. Notably,
silencing of Dact1 in 3T3-J2 cells
enhanced the expression of Tgf-β2,
but not Tgf-β1 or Tgf-β3, in response
to Wnt3A stimulation compared with
control cells at both the mRNA and
protein levels (Figure 2a and b). How-
ever, the basal Tgf-β2 expression was
unchanged in Dact1-silenced 3T3-J2
cells (Figure 2a and b), suggesting that
increased Tgf-β2 expression by 3T3-J2
cells required additional Wnt/β-catenin
stimuli provided by HPEKs. In support,
treatment of 3T3-J2 cells with HPEK-
conditioned medium stimulated Tgf-β2
expression, whereas this effect was
signiﬁcantly suppressed when HPEK-
conditioned media were prepared inAccepted article preview online 22 June 2015; published online 16 July 2015
Abbreviations: Dact1, dapper antagonist of β-catenin 1; HPEK, human primary epidermal keratinocyte;
Igf, insulin-like growth factor; MEF, mouse embryonic ﬁbroblast; TGF-β, transforming growth factor-β
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